Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 27, 2013 - Issue 20
267
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Two new vinblastine-type N-oxide alkaloids from Catharanthus roseus

, , , , , , & show all
Pages 1911-1916 | Received 07 Jan 2013, Accepted 02 Mar 2013, Published online: 27 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Oladipupo A. Lawal, Isiaka A. Ogunwande, Adedoyin E. Ibirogba, Olamide M. Layode & Andy R. Opoku. (2015) Chemical Constituents of Essential Oils from Catharanthus roseus (L.) G. Don Grown in Nigeria. Journal of Essential Oil Bearing Plants 18:1, pages 57-63.
Read now
Tomohiro Itoh, Yuji Muramatsu, Masayo Masu, Ayaka Tsuge, Masaki Taniguchi, Masayuki Ninomiya, Masashi Ando, Yasuyuki Tsukamasa & Mamoru Koketsu. (2014) A Synthesized Nostocionone Derivative Potentiates Programmed Cell Death in Human T-cell Leukemia Jurkat Cells Through Mitochondria via the Release of Endonuclease G. Nutrition and Cancer 66:8, pages 1414-1423.
Read now

Articles from other publishers (11)

Mengwei Xu, Rui Peng, Qing Min, Siwen Hui, Xin Chen, Guang Yang & Shuanglin Qin. (2022) Bisindole natural products: A vital source for the development of new anticancer drugs. European Journal of Medicinal Chemistry 243, pages 114748.
Crossref
Alan A. Veiga, Ana Carolina Irioda, Bassam F. Mogharbel, Sandro J. R. Bonatto & Lauro M. Souza. (2022) Quercetin-Rich Extracts from Onions (Allium cepa) Play Potent Cytotoxicity on Adrenocortical Carcinoma Cell Lines, and Quercetin Induces Important Anticancer Properties. Pharmaceuticals 15:6, pages 754.
Crossref
Sunil Kumar, Bikarma Singh & Ramesh Singh. (2022) Catharanthus roseus (L.) G. Don: A review of its ethnobotany, phytochemistry, ethnopharmacology and toxicities. Journal of Ethnopharmacology 284, pages 114647.
Crossref
Zhen-Tao Deng, Wen-Yan Li, Lei Wang, Zhi-Ping Zhou, Xing-De Wu, Zhong-Tao Ding & Qin-Shi Zhao. (2021) Monoterpene Indole Alkaloids with Cav3.1 T-Type Calcium Channel Inhibitory Activity from Catharanthus roseus. Molecules 26:21, pages 6516.
Crossref
Solomon Tesfaye, Kaleab Asres, Ermias Lulekal, Yonatan Alebachew, Eyael Tewelde, Mallika Kumarihamy & Ilias Muhammad. (2020) Ethiopian Medicinal Plants Traditionally Used for the Treatment of Cancer, Part 2: A Review on Cytotoxic, Antiproliferative, and Antitumor Phytochemicals, and Future Perspective. Molecules 25:17, pages 4032.
Crossref
Shahid AkbarShahid Akbar. 2020. Handbook of 200 Medicinal Plants. Handbook of 200 Medicinal Plants 551 559 .
Zahid H. Siddiqui, B. Hareramdas, Zahid K. Abbas, Talat Parween & Mohammad Nasir Khan. 2018. Anticancer plants: Properties and Application. Anticancer plants: Properties and Application 395 413 .
Abhijit Dey, Anuradha Mukherjee & Madhubrata Chaudhury. 2017. 373 488 .
D. Sathya Prabhu & V. Devi Rajeswari. 2017. Catharanthus roseus. Catharanthus roseus 121 151 .
Xiao-Dong Wang, Chen-Yang Li, Miao-Miao Jiang, Dong Li, Ping Wen, Xun Song, Jun-Da Chen, Li-Xuan Guo, Xiao-Peng Hu, Guo-Qiang Li, Jian Zhang, Chun-Hua Wang & Zhen-Dan He. (2016) Induction of apoptosis in human leukemia cells through an intrinsic pathway by cathachunine, a unique alkaloid isolated from Catharanthus roseus. Phytomedicine 23:6, pages 641-653.
Crossref
Soon Huat Tiong, Chung Yeng Looi, Aditya Arya, Won Fen Wong, Hazrina Hazni, Mohd Rais Mustafa & Khalijah Awang. (2015) Vindogentianine, a hypoglycemic alkaloid from Catharanthus roseus (L.) G. Don (Apocynaceae). Fitoterapia 102, pages 182-188.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.